Sorrento COVIDTRAP(STI-4398) Demonstrates in Preclinical Studies its Ability to Completely Inhibit SARS-CoV-2 Viral Infection In Vitro

Press/Media: Expert Comment

PeriodJun 5 2020

Media coverage

2

Media coverage

  • TitleSorrento COVIDTRAP(STI-4398) Demonstrates in Preclinical Studies its Ability to Completely Inhibit SARS-CoV-2 Viral Infection In Vitro
    Media name/outletIndia Pharma News
    CountryIndia
    Date6/5/20
    PersonsSlobodan Paessler
  • TitleSorrento COVIDTRAP(STI-4398) Demonstrates in Preclinical Studies its Ability to Completely Inhibit SARS-CoV-2 Viral Infection In Vitro
    Media name/outletPressReleasePoint
    CountryIndia
    Date6/5/20
    URLct.moreover.com/?a=42295270247&p=1gw&v=1&x=xs4ETOUqnXAhivdwsr8uoA
    PersonsSlobodan Paessler